This website is intended for patients & providers in the USA only. Prescribing Information.
This website is intended for patients & providers outside of the USA. Prescribing Information.

March 12, 2020

Bioness Announces First United Kingdom Implant for StimRouter Neuromodulation System at Leeds Teaching Hospitals NHS Trust

Following Regulatory Approval, Peripheral Nerve Stimulation Device for Chronic Pain Management Launches at Leading UK Hospital

Continue Reading

January 20, 2020

Bioness Announces StimRouter Milestones at 2020 North American Neuromodulation Society’s Annual Meeting

Company to sponsor Educational Session with leading clinical experts sharing insights on peripheral nerve stimulation

Continue Reading

January 16, 2020

Bioness StimRouter® Neuromodulation System Receives CE Mark Approval for the Treatment of Fecal Incontinence

StimRouter also available in Europe for managing chronic pain and overactive bladder

Continue Reading

December 19, 2019

Bioness Introduces Improved Training Platform for Surgeons Expanding Their Practice to Include the StimRouter Peripheral Nerve Stimulator

Attendees of the 2020 NANS Conference Will be First Clinical Professionals to Review

Continue Reading

November 13, 2019

Published Clinical Success for Bioness StimRouter Peripheral Nerve Stimulator

Bioness, Inc., the leading provider of the advanced, clinically supported StimRouter® Peripheral Nerve Stimulator, announced a publication entitled “Prospective Case Series on the Use of Peripheral Nerve Stimulation for Focal Mononeuropathy Treatment” in the journal Pain Management on November 6, 2019.

Continue Reading

September 04, 2019

Bioness Announces Preliminary European Post-Approval Results of StimRouter® Neuromodulation System for the Treatment of Overactive Bladder at the 49th International Continence Society Annual Meeting

StimRouter helping improve lives of patients in Europe and Australia beyond the management of chronic pain

Continue Reading

March 13, 2019

Bioness Announces First Australian Implant of StimRouter® Neuromodulation System at Nambour Selangor Private Hospital

Device now available in Australia for the management of chronic pain

Continue Reading

February 18, 2019

Bioness StimRouter® Neuromodulation System Receives CE Mark Approval for the Treatment of Overactive Bladder (OAB)

StimRouter now available in Europe beyond the management of chronic pain

Continue Reading

January 17, 2019

Bioness to Sponsor Educational Session on Peripheral Nerve Stimulation at 2019 North American Neuromodulation Society’s Annual Meeting

Clinical experts will share insights on present and future applications of neuromodulation technology

Continue Reading

January 14, 2019

Bioness Introduces First Peripheral Nerve Stimulation Registry with its StimRouter™ Neuromodulation System

The company continues to lead the market through the collection of PNS outcomes and ongoing education

Continue Reading